Compare REF & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REF | SLBT |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.5M | 846.7M |
| IPO Year | 2026 | 2025 |
| Metric | REF | SLBT |
|---|---|---|
| Price | $13.60 | $1.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $19.25 | N/A |
| AVG Volume (30 Days) | ★ 555.6K | 71.8K |
| Earning Date | 11-03-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.39 | N/A |
| Revenue Next Year | $16.23 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.85 | $1.42 |
| 52 Week High | $17.26 | $6.25 |
| Indicator | REF | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 50.77 | 35.52 |
| Support Level | $12.90 | $1.42 |
| Resistance Level | $16.24 | $1.98 |
| Average True Range (ATR) | 0.61 | 0.13 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 73.54 | 23.42 |
Reformation Inc sells apparel and accessories through its website, company-owned retail stores, wholesale channels, and other distribution channels in the United States and internationally. Its product portfolio includes dresses, bottoms, tops, sweaters, and accessories. The company focuses on womenswear and sources materials and products through its supply chain operations. The majority of the company's revenue was derived from the sale of its apparel and accessories, including clothing, shoes, and bags, through e-commerce and retail. Geographically, the maximum revenue is generated from the United States.
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.